We are proud to report the most recent, breakthrough results on selective anticancer gold nanoparticles (AuNPs) based on our leading charged ligands MUA and TMA and mixed charge AuNP class of products being offered since years to our customers. The 16th March 2020 Nature Nanotechnology article published by our valued colleagues from ULSAN reveals the phenomena of mechanism causing death of cancer cells. A ‘must read’ to all Nanomedicine and pharmaceutical specialists available now at https://rdcu.be/b21hN